... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
chalcogen molecular entity >
oxygen molecular entity >
organooxygen compound >
carbonyl compound >
n-[(2r,4ar,12ar)-2-[2-[[(3r)-1-benzylpyrrolidin-3-yl]amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-3,4-difluorobenzamide
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
chalcogen molecular entity >
organochalcogen compound >
organooxygen compound >
carbonyl compound >
n-[(2r,4ar,12ar)-2-[2-[[(3r)-1-benzylpyrrolidin-3-yl]amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-3,4-difluorobenzamide
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
carbon group molecular entity >
organic molecular entity >
heteroorganic entity >
organochalcogen compound >
organooxygen compound >
carbonyl compound >
n-[(2r,4ar,12ar)-2-[2-[[(3r)-1-benzylpyrrolidin-3-yl]amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-3,4-difluorobenzamide
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
carbon group molecular entity >
organic molecular entity >
organic molecule >
organic oxo compound >
carbonyl compound >
n-[(2r,4ar,12ar)-2-[2-[[(3r)-1-benzylpyrrolidin-3-yl]amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-3,4-difluorobenzamide
... >
chemical entity >
molecular entity >
polyatomic entity >
molecule >
organic molecule >
organic oxo compound >
carbonyl compound >
n-[(2r,4ar,12ar)-2-[2-[[(3r)-1-benzylpyrrolidin-3-yl]amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-3,4-difluorobenzamide
... >
chemical entity >
molecular entity >
polyatomic entity >
heteroatomic molecular entity >
halide >
organohalogen compound >
n-[(2r,4ar,12ar)-2-[2-[[(3r)-1-benzylpyrrolidin-3-yl]amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-3,4-difluorobenzamide
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
halogen molecular entity >
halide >
organohalogen compound >
n-[(2r,4ar,12ar)-2-[2-[[(3r)-1-benzylpyrrolidin-3-yl]amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-3,4-difluorobenzamide
... >
chemical entity >
molecular entity >
main group molecular entity >
p-block molecular entity >
carbon group molecular entity >
organic molecular entity >
heteroorganic entity >
organohalogen compound >
n-[(2r,4ar,12ar)-2-[2-[[(3r)-1-benzylpyrrolidin-3-yl]amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-3,4-difluorobenzamide
Preferred term
n-[(2r,4ar,12ar)-2-[2-[[(3r)-1-benzylpyrrolidin-3-yl]amino]-2-oxoethyl]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-8-yl]-3,4-difluorobenzamide
inchi
-
InChI=1S/C34H36F2N4O5/c1-39-29-11-9-25(17-32(41)37-24-13-14-40(19-24)18-21-5-3-2-4-6-21)45-31(29)20-44-30-12-8-23(16-26(30)34(39)43)38-33(42)22-7-10-27(35)28(36)15-22/h2-8,10,12,15-16,24-25,29,31H,9,11,13-14,17-20H2,1H3,(H,37,41)(H,38,42)/t24-,25-,29-,31+/m1/s1
inchikey
-
UWMJOJNRDSZDAZ-ZDLWVMCGSA-N
smiles
-
CN1[C@@H]2CC[C@@H](O[C@H]2COC3=C(C1=O)C=C(C=C3)NC(=O)C4=CC(=C(C=C4)F)F)CC(=O)N[C@@H]5CCN(C5)CC6=CC=CC=C6
-
N [(2R,4aR,12aR) 2 [2 [[(3R) 1 benzylpyrrolidin 3 yl]amino] 2 oxoethyl] 5 methyl 6 oxo 2,3,4,4a,12,12a hexahydropyrano[2,3 c][1,5]benzoxazocin , 4, 8 .
URI
http://www.irandoc.acir/onto/irandoc/CHEBI:98103